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a b s t r a c t
The anticoagulant rodenticide diphacinone was slightly toxic (acute oral LD50 2014 mg/kg) to Northern
bobwhite (Colinus virginianus) in a 14-day acute toxicity trial. Precise and sensitive assays of blood
clotting (prothrombin time, Russell’s Viper venom time, and thrombin clotting time) were adapted for
use in quail, and this combination of assays is recommended to measure the effects of anticoagulant
rodenticides. A single oral sublethal dose of diphacinone (434 mg/kg body weight) prolonged clotting
time at 48 h post-dose compared to controls. At 783 mg/kg (approximate LD02), clotting time was
prolonged at both 24 and 48 h post-dose. Prolongation of in vitro clotting time reflects impaired
coagulation complex activity, and was detected before overt signs of toxicity were apparent at the
greatest dosages (2868 and 3666 mg/kg) in the acute toxicity trial. These clotting time assays and
toxicity data will assist in the development of a pharmacodynamic model to predict toxicity, and also
facilitate rodenticide hazard and risk assessments in avian species.
Published by Elsevier Inc.
1. Introduction
Public concern over poisoning of non-target wildlife began in
the early 20th century when strychnine and thallium used for
rodent and predator control were observed to be affecting species
like quail and song birds (Peterle, 1991). In the 1930s, Link
investigated the hemorrhagic effects of improperly cured sweet
clover (Melilotus spp.) in domestic livestock, and eventually
isolated 3,3’-methylene-bis(4-hydroxycoumarin) (i.e., dicumarol)
(Pelfrene, 1991). This discovery ultimately led to the synthesis of
over 100 analogs, including warfarin that was eventually used as a
rodenticide. The mechanism of action of warfarin, and other
anticoagulant rodenticides, involves inhibition of synthesis of
functional vitamin K-dependent factors including prothrombin.
Several current use anticoagulant rodenticides pose hazard to
ground feeding birds by direct ingestion of bait (primary
poisoning) and to predatory and scavenging birds by consumption
of poisoned rodents or exposed invertebrate prey (secondary
poisoning). Non-target exposure and effects of anticoagulant
rodenticides in wildlife have been documented in many countries,
including the United States, United Kingdom, France, Canada,
Malaysia and New Zealand (e.g., Albert et al., 2009; Eason and
Spurr, 1995; Howald et al., 1999; Lambert et al., 2007; Stone et al.,
1999, 2003; Walker et al., 2008). For example, in New York State
there were at least 51 confirmed cases of death by hemorrhage
with detection of rodenticides in tissues of wildlife between 1971
and 1997, with over half of the incidents involving birds of prey
(e.g., great horned owl, Bubo virginianus; red-tailed hawk, Buteo
jamaicensis) (Stone et al., 1999). Based on these findings, an
anticoagulant surveillance program was implemented between
1998 and 2001 for routine avian submissions to the New York
State Wildlife Pathology Unit. Remarkably, 49% of 265 raptors had
detectable quantities of anticoagulants in liver tissue, and anti-
coagulants were considered the cause of death in nearly 15% of
these cases (Stone et al., 2003). On a global scale, the magnitude of
the hazard of rodenticides to birds is not well-characterized
because the effect of sublethal exposure on long-term survival
and fitness is unknown, and most lethal poisoning events are
probably unnoticed or not reported.
In 2002, the US Environmental Protection Agency (US EPA)
completed a risk assessment that identified several rodenticides
that posed a significant risk to birds and non-target mammals
(Erickson and Urban, 2004). Subsequently, the US EPA (2008)
released its final ecological risk mitigation decision that placed
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some restrictions on the sale, distribution and packaging
of several second generation rodenticides (i.e., brodifacoum,
difethialone, bromadiolone and difenacoum) that have greater
toxicity and are more persistent in tissues than first generation
rodenticides. This action will likely be offset by expanded use of
other anticoagulant rodenticides, including diphacinone (classi-
fied as a first or intermediate generation compound). Unfortu-
nately, the hazard posed by diphacinone to non-target organisms
is inadequately characterized. Median lethal dosages, sublethal
responses and tissue concentrations are being generated in both
traditional wildlife test species (e.g., Northern bobwhite, Colinus
virginianus) and in birds of prey that are occasionally used in
toxicity tests (e.g., American kestrels, Falco sparverius and Eastern
screech owls, Megascops asio) (Rattner et al., 2010). Various
measurement endpoints are being used to develop a physiolog-
ically based pharmacokinetic model (PBPK) that will facilitate
estimation of diphacinone burdens and risk to avian species. One
endpoint critical to this effort is the measurement of blood
clotting time. The effects of anticoagulant rodenticides on
hemostasis are better characterized in mammals than in birds.
This may be attributable to several factors including greater
societal concerns for humans, domesticated and companion
mammals, inter-specific differences in blood clotting pathways
that influence coagulation testing (Fig. 1; Powers, 2000; Thomson
et al., 2002) and limited commercial availability of reagents and
controls optimized for use in birds. As an initial step in
determining the toxicity of diphacinone to avian species, blood
clotting assays were adapted for use in bobwhite. Hopefully, such
diphacinone toxicity data and the PBPK model will assist in
selection of efficacious baiting strategies that may mitigate risk to
non-target species.
2. Methods
2.1. Animals and diphacinone dosing
Animal procedures were approved by the Institutional Animal Care and Use
Committees of the National Wildlife Research Center (NWRC), Animal and Plant
Health Inspection Service of the US Department of Agriculture (USDA) and the
Patuxent Wildlife Research Center (PWRC), US Geological Survey (USGS) of the
Department of the Interior. Adult Northern bobwhite were obtained from R & R
Game Birds (Lamar, CO), and housed individually in indoor pens (614633 cm3
high) at NWRC. Bobwhite quail were maintained in a 12 h light: 12 h dark
photoperiod at 18–21 1C, and provided food (Purina Game Bird Maintenance
Chows Product 5440, 12.5% protein, Denver, CO) and water ad libitum.
An acute oral toxicity study was conducted in bobwhite (weight range:
149–224 g) gavaged with technical grade diphacinone (99% active ingredient;
Hacco, Inc. Randolph, WI) suspended in pure vegetable oil (soybean oil
cholesterol-free; Criscos, Orrville, OH). The selection of doses was somewhat
problematic as existing data suggested that the slope of the dose–response curve
was steep, and doses were too widely separated to permit estimation of a reliable
median lethal dose (Campbell et al., 1991; US EPA, 1998). Accordingly, the study
was conducted over a six week period using analytically determined diphacinone
doses that were selected through an iterative process (917, 965, 1033, 2065, 2868
and 3666 mg/kg body weight; n¼910 bobwhite/dose; approximately equal
distribution of sexes/dose). Because of low solubility, diphacinone was
administered as slurry in vegetable oil (heaviest bird in a dose group received
1 ml and the remaining birds received a fractional volume related to their weight,
0.76–0.99 ml). Some target doses could only be achieved by repeatedly adminis-
tering a divided dose over a 24-h period (target exposure of 1033 and 2065 mg/kg:
2 doses/day; target exposure of 2868 mg/kg: 3 dose/day and target exposure of
3666 mg/kg: 4 doses/day). Moderate volumes of the vehicle were also adminis-
tered 1–3 times to controls (n¼9) during a 24-h period. Birds were observed twice
daily for signs of toxicity over a 14-day period.
Based upon the results of this acute toxicity trial, a second study was
conducted in which bobwhite (weight range: 178–241 g) were gavaged with
either vegetable oil (control n¼6), or with analytically determined doses of
diphacinone at 434 mg/kg (n¼16) or 783 mg/kg (n¼16). At 6, 12, 24 and 48 h
post-dose, each bird was euthanized with carbon dioxide and immediately bled by
cardiac puncture. Controls were sacrificed and bled at 48 h post-dose. Blood
samples (0.5 ml) were collected into syringes containing 50 ml 0.5 M EDTA, a
suitable alternative to sodium citrate (Cero´n et al., 2008). Blood samples were
centrifuged, plasma harvested and frozen at 80 1C, and subsequently shipped to
the PWRC for analysis.
2.2. Analytical determination of diphacinone in dosing solutions
For determination of diphacinone concentration in dosing solutions, 100 ml of
the slurry was weighed and dissolved in 10 ml of 1:1 acetone:chloroform, and
10 ml was diluted to 10 ml with 5 mM tetrabutylammonium phosphate in 12 mM
phosphate buffer (pH 8.5) and methanol (40:60 ratio). The sample was placed in
an ultrasonic bath for 5 min, filtered through a 0.45 mm teflon syringe filter into an
amber vial, and analyzed by reverse phase ion-paired high-performance liquid
chromatography with concentrations determined by comparison to a calibration
standard (Primus et al., 1996). The method detection limit was 4 ng/ml and the
precision (mean coefficient of variation7standard deviation) for triplicate
determinations was 3.371.5% (n¼3).
2.3. Clotting assays
One-stage prothrombin time, Russell’s Viper venom time, and thrombin
clotting time were measured in plasma samples using a thermostatically
controlled BBL fibrometer (Becton Dickson & Co., Baltimore, MD) (Miale, 1965).
Upon addition of reagents and plasma into a sample cup, a clot detection arm with
a stationary electrode and a moving electrode automatically drop into the cup, and
the formation of a fibrin clot between the electrodes (measurement endpoint) is
determined by a detection circuit linked to a timer.
2.3.1. One-stage prothrombin time assay
In this assay, an excess of tissue factor and phospholipid (thromboplastin)
interacts with plasma Factor VII to form an active complex, and through a cascade
of subsequent reactions (Factor X activation, conversion of prothrombin to
thrombin) fibrinogen is eventually converted to fibrin which forms the clot (Fig. 1).
Crude chicken hatchling thromboplastin was prepared by the method of Quick as
modified by Griminger et al. (1970) and Doerr et al. (1975). The cerebral cortex of
3-day old broiler chicks (Gallus gallus) was removed, weighed and homogenized in
10 volumes of cold acetone. This suspension was centrifuged at 1500g for 10 min,
and the supernatant was discarded. The pellet was re-suspended in 5 ml of
acetone, homogenized, centrifuged, acetone decanted, and this procedure was
repeated. The pellet was then re-suspended in acetone, vacuum filtered using a
Bu¨chner funnel with a glass microfiber filter (Whatman 934-AH, 1.5 mm retention,
Fisher Scientific, Suwanee, GA). The material retained on the filter was dried over
night in a vacuum desiccator, removed from the microfiber filter, ground with a
mortar and pestle, and transferred into cryotubes which were frozen at 80 1C.
For the one-stage prothrombin time assay, 50 mg of the crude chicken
hatchling thromboplastin (CHT) was suspended in 2500 ml of 25 mM CaCl2, and
incubated at 42 1C for 15 min with intermittent vortexing. This suspension was
centrifuged at 1500g for 20 min, and the supernatant was further diluted (1:1)
with 25 mM CaCl2 (final concentration 220 mg protein/ml, BCATM Protein Assay
Kit, Pierce, Rockford, IL). Plasma (100 ml) was incubated at 37 1C in a sample cup
for 2 min, and the reaction was initiated with the addition of 200 ml of the CHT.
Samples were generally analyzed in duplicate, and the performance of the
fibrometer was routinely checked using human plasma reference standards
Fig. 1. Blood coagulation pathway in birds (adapted from Gentry, 1993 and
Thomson et al., 2002; F¼Factor, PL¼phospholipid).
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incubated with Simplastins (rabbit brain thromboplastin; Trinity Biotech,
Berkeley Heights, NJ). Intra-assay precision (mean coefficient of variation7
standard deviation) for duplicate determinations of bobwhite plasma with CHT
was 4.674.5% (n¼30). Inter-assay precision over the course of a year for human
reference samples using Simplastins was 2.972.2% (n¼13). When the CHT
solution was diluted, clotting time of bobwhite plasma was found to increase
(Fig. 2). When bobwhite plasma was diluted with 8.3 mM sodium potassium
phosphate buffer (pH 7.2), clotting time was relatively stable at plasma dilutions
ranging between 40% and 80%, but increased dramatically at dilutions containing
less than 20% plasma (Fig. 3).
2.3.2. Russell’s Viper venom time (RVVT)
In this assay, Russell’s Viper venom (RVV) directly activates Factor X (but not
Factor VII) in the common pathway of the clotting cascade (Fig. 1). Reconstituted
RVV Factor X activator (American Diagnostica, Stamford, CT) was diluted 1:10 with
imidazole buffered saline (IBS; 0.0125 M imidazole 0.109 M NaCl, pH 7.4) and
maintained at room temperature. Plasma (100 ml) was incubated at 37 1C in a
sample cup for 2 min, and 100 ml of diluted RVV was added to the sample cup and
incubated for 15 s. The clotting reaction was initiated with 100 ml 25 mM CaCl2, and
time to clot was measured (Triplett and Harms, 1981a). Intra-assay precision for
duplicate determinations of bobwhite plasma was 6.5713.5% (n¼19). Clotting time
remained relatively stable when bobwhite plasma was diluted by as much as 60%
with phosphate buffer, but RVVT increased dramatically at greater dilutions (Fig. 4).
2.3.3. Thrombin clotting time (TCT)
This assay measures the time for conversion of fibrinogen to fibrin (Fig. 1)
using a standard thrombin solution (Triplett and Harms, 1981b). This assay is
insensitive to deficiency of vitamin K-dependent clotting factors but is an indicator
of the amount of fibrinogen in the plasma sample. Fibrinogen deficiency from
improper sample collection and handling can prolong prothrombin time and
RVVT, and thus affect test method accuracy (increase false positive rate). For this
heterologous assay, bovine thrombin reagent and human fibrinogen reference
material was used (AMAX Fibrinogen kit, Trinity Biotech). A fibrinogen standard
curve was prepared (65–520 mg/dL), and bobwhite plasma samples were diluted
1:10 with IBS. Diluted plasma (200 ml) was incubated at 37 1C in a sample cup for
2 min, and the reaction initiated by the addition of 100 ml of thrombin reagent.
Clotting time of the test sample is transformed to fibrinogen concentration
(mg/dL) from the fibrinogen standard curve. Intra-assay precision for duplicate
determinations of bobwhite plasma was 5.776.8% (n¼32).
2.4. Statistical methods
For the acute toxicity trial, the relation between diphacinone dose and
survival, and estimates of the slope, median lethal dose (LD50) and 95% confidence
interval were determined using the probit analysis procedure in SAS (SAS Institute,
Carey, NC). In the sublethal dosing study, prothrombin time, RVVT and TCT
measurement endpoints were tested for homogeneity of variance (Fmax test) and
normality (Shapiro–Wilk test, normal probability plot and descriptive statistics).
Homogeneity of variance and normality were improved following log-transforma-
tion, and measurement endpoints were then compared by analysis of variance
(ANOVA) and a Tukey’s HSD test. A regression ANOVA was used to examine the
relation between prothrombin time and dilution of the CHT. A one-phase decay
model (Prism, GraphPad Software, Inc., La Jolla, CA) was used to describe the
relation between clotting time and dilution of bobwhite plasma in the
prothrombin time and RVVT assays.
3. Results
3.1. Acute and sublethal toxicity studies
Survival of bobwhite was significantly related (po0.0001) to
dose of diphacinone (9 of 10 survivors at 917 mg/kg, 8 of 9 at
965 mg/kg, 10 of 10 at 1033 mg/kg, 7 of 10 at 2065 mg/kg, 1 of 10
at 2868 mg/kg and 0 of 10 at 3666 mg/kg), with most of the birds
receiving greatest doses (2868 and 3666 mg/kg) dying within 1–3
days of exposure. Some of the dosed bobwhite seemed lethargic,
and had fluffed feathers. Several of the birds that succumbed had
subcutaneous bruises in the breast and back regions, which could
reflect coagulopathy; however, there was no evidence of frank
internal or external bleeding. Controls that had been dosed
multiple times with vehicle in a 24 h period did not exhibit overt
signs of toxicity. The LD50 was estimated to be 2014 mg/kg
(95% confidence interval 1620–2475 mg/kg), and the slope
of the dose–response curve was steep (probit/log107standard
error¼9.9272.27).
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Fig. 2. Clot promoting potential of undiluted (0) and diluted (1:4, 1:16 and 1:64)
chicken hatchling thromboplastin incubated with bobwhite plasma. Prothrombin
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plasma) with phosphate buffer on prothrombin time (prothrombin time¼
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Fig. 4. Effect of diluting bobwhite plasma (100%, 80%, 60%, 50%, 40%, 30%, 20% and
15% plasma) with phosphate buffer on Russell’s Viper venom clotting time
(RVVT¼28.0+3514e0.16(%plasma); R2¼0.99).
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Based on this dose–response curve, the 783 mg/kg dose in the
sublethal trial falls in the LD01–LD02 range, and the 434 mg/kg
dose is just slightly greater than the lower 95% confidence limit of
the LD01. All bobwhite receiving these doses survived and did not
exhibit overt signs of toxicity.
3.2. Clotting time
Administration of 434 and 783 mg diphacinone/kg body
weight prolonged clotting time when compared to controls, but
the temporal response was highly variable (Figs. 5 and 6).
However, the fibrinogen concentration in 5 samples was
undetectable, and the volume was too small to determine
fibrinogen concentration in another sample. The absence of
fibrinogen in these 5 samples suggests that they may have been
collected improperly (viz., cardiac puncture of euthanized birds,
blood sample partially clotted). Fibrinogen is generally in great
excess, and its cleavage to fibrin in the TCT assay is not influenced
by vitamin K antagonists. When these 6 samples were excluded,
all remaining samples (n¼32) contained more than 60 mg
fibrinogen/dL plasma (range: 63–254 mg/dL). For these
remaining samples, prothrombin time (Fig. 7) and RVVT (Fig. 8)
were prolonged (po0.05; factors of 3.9 and 4.4) at 48 h after
administration of 434 mg/kg when compared to the control
group. Following administration of diphacinone at 783 mg/kg,
prothrombin time and RVVT were prolonged at both 24 h
(po0.05; factors of 2.5 and 2.8) and 48 h (po0.05, factors of
4.1 and 3.6) when compared to the control group.
4. Discussion
Using categories of toxicity that describe harm (Loomis, 1978),
results of the 14-day acute toxicity test suggest that diphacinone
may be classified as only slightly toxic (LD50 2014 mg/kg) to
Northern bobwhite. In a previous study (Campbell et al., 1991), a
reliable median lethal dose for diphacinone in bobwhite could not
be estimated (dosing concentrations were separated by a factor of
5), although inspection of the data suggest that the theoretical
value fell between 400 and 2000 mg/kg (US EPA, 1998). Our
estimated LD50 in bobwhite is within the same order of
Fig. 5. Prothrombin time (mean7standard deviation;  ¼data point) of all
bobwhite gavaged with vehicle (control) or diphacinone (6, 12, 24 and 48 h
post-dose).
Fig. 6. Russell’s Viper venom time (mean7standard deviation;  ¼data point) of
all bobwhite gavaged with vehicle (control) or diphacinone (6, 12, 24 and 48 h
post-dose).
Fig. 7. Prothrombin time (mean7standard deviation) of bobwhite gavaged with
vehicle (control) or diphacinone (6, 12, 24 and 48 h post-dose) with plasma
fibrinogen460 mg /dL. n¼significantly different (po0.05) than control.
Fig. 8. Russell’s Viper venom time (mean7standard deviation) of bobwhite
gavaged with vehicle (control) or diphacinone (6, 12, 24 and 48 h post-dose) with
plasma fibrinogen460 mg /dL. n¼significantly different (po0.05) than control.
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magnitude as that reported in mallards (Anas platyhrynchos;
3158 mg/kg) (Erikson and Urban, 2004). Based upon these data,
technical grade diphacinone appears to be considerably less toxic
to birds than to laboratory rats (range of estimated LD50
1.9–7 mg/kg), domesticated mammals (0.8–15 mg/kg), and wild
mammals (0.2–340 mg/kg) (reviewed in Eisemann and Swift,
2006; Erikson and Urban, 2004). Accordingly, diphacinone baits or
environmental residues would seemingly present a reduced
hazard to birds compared to mammals. Nonetheless, it has been
linked to secondary poisoning in raptors (Stone et al., 1999, 2003).
Furthermore, results of a recent 7-day acute oral toxicity study in
American kestrels (F. sparverius) found diphacinone to be
moderately toxic (LD50 97 mg/kg) (Rattner et al., 2010), suggest-
ing that extrapolation of diphacinone toxicity from Northern
bobwhite and mallards to other avian orders (e.g., Falconiformes,
Stringiformes) may be dubious, and protection of raptors may
require substantial safety factors.
Three coagulation assays were adapted that yielded short and
precise clotting times with EDTA-treated plasma from bobwhite.
Using a thromboplastin extract from chicken hatchlings, pro-
thrombin time of untreated bobwhite (mean7standard devia-
tion: 15.271.5 s, Fig. 7) was in the range of values reported for
several species of domesticated birds (chicken; turkey, Meleagris
gallopavo; Japanese quail, Coturnix coturnix) and wild birds (e.g.,
black ducks, Anas supercillosa; American kestrels; Eastern screech
owls, M. asio; black kite, Milus migrans; Egyptian vulture,
Neophron percnopterus; wedge-tailed eagles, Aquila audax; pigeon,
Columba livia; bronzewing pigeons, Phaps chalcoptera; Hispanio-
lan parrot, Amazona ventralis; umbrella cockatoo, Cacatua alba;
Port Lincoln parrots, Barnardius zonarius; Australian magpies,
Gymnorhina tibicen) (Martin et al., 1994; Morrisey et al., 2003;
reviewed in Powers, 2000; Rattner et al., 2009; Thomson et al.,
2002; Webster, 2009). Using RVV that activates Factor X in the
common pathway, clotting time of plasma from untreated
bobwhite (39.578.9 s, Fig. 8) was greater than that reported in
several avian species (9–21 s; Tahira et al. 1977; Timms, 1977),
although precision for duplicate determinations (coefficient of
variation 6.5%) and the standard deviation of the 5 control
samples with 460 mg fibrinogen/dL seems acceptable. The
volume of all plasma samples analyzed in the one-stage
prothrombin time and RVVT assays was 100 ml, although dilution
curves (Figs. 3 and 4) suggest that reagent incubation conditions
permit much smaller volumes with only minimal effects on
clotting time. Similar findings have been reported for prothrom-
bin time assays in chicken (Bailey et al., 2005) and Japanese quail
(Webster, 2009), and by using dilution curves, one could normal-
ize clotting time of samples of variable volumes to a constant
volume (e.g., 100 ml) (Bailey et al., 2005).
Anticoagulant rodenticides inhibit vitamin K-dependent post-
translational processing of clotting Factors II (prothrombin), VII,
IX and X (reviewed in Powers, 2000), but do not affect the
synthesis of fibrinogen. Fibrinogen deficiency resulting from
pathophysiologic conditions (e.g., hepatic synthetic failure, dis-
seminated intravascular coagulation, fluid resuscitation after
massive blood loss) or from improper sample collection practices
can prolong in vitro clotting time. To date, avian studies
examining anticoagulant rodenticide toxicity have failed to
determine if sample fibrinogen content supports in vitro clot
formation. Such a fibrinogen concentration threshold is yet to be
established for birds, and in the interim, we used 60 mg/dL. Thus,
a conservative diagnostic approach for anticoagulant rodenticide
laboratory and field studies that evaluate vitamin K-dependent
coagulopathies would entail a combination of assays, namely
prothrombin time and/or RVVT, plus determination of fibrinogen
to rule out any nonspecific influence on clotting time. Shlosberg and
Booth (2006) have proposed that prolongation of prothrombin
time by more than 25% is suggestive of anticoagulant exposure.
Consideration should be given to standardizing avian thrombo-
plastin preparations (e.g., International Normalized Ratios) and
developing reference values for wild birds to facilitate interpreta-
tion of field exposure monitoring. In the absence of standardized
avian thromboplastin preparations, RVVT offers the advantage of
inter-laboratory comparisons as reagents are commercially avail-
able. Ideally, exposure should be confirmed by clotting time
endpoints, fibrinogen concentration, and analytical detection of
anticoagulant residues in blood or tissue.
In the present study, several samples did not contain
detectable quantities of fibrinogen, failed to clot in both the
one-stage prothrombin time and RVVT assays, and thus, were
excluded from our evaluation of the effects of diphacinone on
hemostasis. Clotting time of samples with detectable fibrinogen
(460 mg/dL) was not affected at 6 and 12 h after administration
of diphacinone, but was prolonged at 24 and 48 h post-dosage.
This time course corresponds with, and may precede, the onset of
overt toxicity and lethality at high dosage levels used in the acute
toxicity study. The lag time between dosing and development of
coagulopathy reflects the half-life clearance of functional coagu-
lation factors and the increasing circulation of des-carboxy,
dysfunctional factors. Diphacinone’s irreversible inhibition of
hepatic vitamin K epoxide reductase impairs post-translational
carboxylation of the prothrombin group of serine protease
coagulation factors (Factors II, VII, IX and X). Without the addition
of a carboxyl group, these factors are unable to assemble on cell
surfaces to form active coagulation complexes. Related studies in
American kestrel have shown a similar time course for prolonged
clotting time following diphacinone administration (peak effect at
48 h post-dose), and also demonstrated that clotting time returns
to control levels by day 7 post-exposure (Rattner et al., 2010).
Detection of prolonged prothrombin time is used as an early
indicator of anticoagulant rodenticide ingestion in domestic
mammals, and prothrombin time is used routinely to monitor
coumadin anticoagulant therapy in people (Mount and Feldman,
1983; Spinler et al., 2005). Prolonged prothrombin times have
been reported within days of: (1) dietary exposure to diphacinone
(American crow, Corvus brachyrhynchos, Massey et al., 1997;
golden eagles, Aquila chrysaetos, Savarie et al., 1979), warfarin
(chickens, Veltmann et al., 1981) and brodifacoum (Japanese
quail, Webster, 2009), (2) repeated gavage with pindone (wedge-
tailed eagles, bronzewing pigeons, Port Lincoln parrots, black
ducks, Australian magpies, Martin et al., 1994) and (3) intrave-
nous injection of warfarin (chickens, Stopforth, 1970). Aside from
evoking outright mortality due to hemorrhage, prolonged clotting
time constitutes a change in fitness that could affect tolerance to
normal physiological events (e.g., blood loss associated with molt)
and environmental stressors (e.g., exposure to contaminants that
impair hematopoiesis, altered nutritional plane).
5. Conclusion
Diphacinone was found to be of low acute oral toxicity to
Northern bobwhite, with effects on coagulation detectable at
sublethal concentrations. A series of clotting assays were devel-
oped and applied for use in bobwhite that are sensitive, precise,
inexpensive, linked to the pathogenesis of toxicity (and ultimately
mortality), and have applicability as biomarkers in both con-
trolled laboratory studies and field monitoring. Determination of
prothrombin time and/or Russell’s Viper venom time, plus
fibrinogen concentration to exclude nonspecific influences on
clotting, is recommended for diagnostic purposes. These findings
and assay methods will assist in the development of a pharmaco-
dynamic model to predict toxicity, and also facilitate rodenticide
B.A. Rattner et al. / Ecotoxicology and Environmental Safety 73 (2010) 1159–1164 1163
hazard and risk assessments of secondary poisoning in avian
species.
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